LYEL
Price
$9.74
Change
-$0.00 (-0.00%)
Updated
Jun 13 closing price
Capitalization
144.23M
52 days until earnings call
TRDA
Price
$7.59
Change
-$0.26 (-3.31%)
Updated
Jun 13 closing price
Capitalization
288.07M
52 days until earnings call
Interact to see
Advertisement

LYEL vs TRDA

Header iconLYEL vs TRDA Comparison
Open Charts LYEL vs TRDABanner chart's image
Lyell Immunopharma
Price$9.74
Change-$0.00 (-0.00%)
Volume$76.73K
Capitalization144.23M
Entrada Therapeutics
Price$7.59
Change-$0.26 (-3.31%)
Volume$117.87K
Capitalization288.07M
LYEL vs TRDA Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. TRDA commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and TRDA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (LYEL: $9.74 vs. TRDA: $7.59)
Brand notoriety: LYEL and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 64% vs. TRDA: 81%
Market capitalization -- LYEL: $144.23M vs. TRDA: $288.07M
LYEL [@Biotechnology] is valued at $144.23M. TRDA’s [@Biotechnology] market capitalization is $288.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • LYEL’s TA Score: 5 bullish, 5 bearish.
  • TRDA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а -23.67% price change this week, while TRDA (@Biotechnology) price change was -8.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

LYEL is expected to report earnings on Aug 06, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($288M) has a higher market cap than LYEL($144M). LYEL YTD gains are higher at: -23.906 vs. TRDA (-56.102). TRDA has higher annual earnings (EBITDA): 7.89M vs. LYEL (-204.02M). TRDA has more cash in the bank: 383M vs. LYEL (301M). LYEL has less debt than TRDA: LYEL (48.9M) vs TRDA (57M). TRDA has higher revenues than LYEL: TRDA (172M) vs LYEL (65K).
LYELTRDALYEL / TRDA
Capitalization144M288M50%
EBITDA-204.02M7.89M-2,585%
Gain YTD-23.906-56.10243%
P/E RatioN/A13.09-
Revenue65K172M0%
Total Cash301M383M79%
Total Debt48.9M57M86%
TECHNICAL ANALYSIS
Technical Analysis
LYELTRDA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend about 1 month ago
83%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MBIRX53.27-0.47
-0.87%
Morgan Stanley Insight IR
UEPIX17.43-0.18
-1.02%
ProFunds Europe 30 Inv
JHBCX62.30-1.00
-1.58%
JHancock Blue Chip Growth NAV
BUFSX13.97-0.24
-1.69%
Buffalo Small Cap Growth
EACPX57.56-1.05
-1.79%
Eaton Vance Tax-Managed Multi-Cap Gr A

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with TYRA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then TYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
N/A
TYRA - LYEL
41%
Loosely correlated
+0.97%
CRBU - LYEL
41%
Loosely correlated
-4.31%
PRME - LYEL
39%
Loosely correlated
N/A
TRDA - LYEL
39%
Loosely correlated
-3.31%
OLMA - LYEL
36%
Loosely correlated
+2.71%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-3.31%
CRNX - TRDA
58%
Loosely correlated
-1.24%
ATXS - TRDA
53%
Loosely correlated
+2.14%
BEAM - TRDA
52%
Loosely correlated
-2.18%
RXRX - TRDA
52%
Loosely correlated
-4.84%
IMNM - TRDA
52%
Loosely correlated
-6.03%
More